AKVA group ASA (AKVA.OL)
NOK 62.2
(-0.64%)
NOK 62.2
(-0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 194.8 Million | 218.16 Million | 60.75 Million | 304.97 Million | 210.76 Million | 153.91 Million |
| Net Income | -17.83 Million | -151.86 Million | 2.54 Million | 121.47 Million | 13.47 Million | 111.51 Million |
| Depreciation & Amortization | 195.8 Million | 214.76 Million | 182.66 Million | 190.92 Million | 209.59 Million | 107.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 16.82 Million | 153.79 Million | -85.88 Million | 30.02 Million | 41.78 Million | -39.58 Million |
| Other non-cash items | 15 Thousand | 1.47 Million | -38.57 Million | -37.46 Million | -54.08 Million | -25.91 Million |
| Investing Cash Flow | -246.73 Million | -120.89 Million | -113.92 Million | -188.4 Million | -140.09 Million | -270.67 Million |
| Investments in PPE | -221.35 Million | -167.85 Million | -80.33 Million | -103.19 Million | -141.9 Million | -99.05 Million |
| Acquisitions | -33.43 Million | 40 Million | 2.62 Million | -90.54 Million | 2.59 Million | -168.27 Million |
| Investment purchases | - | -40 Million | -36.21 Million | -38.58 Million | - | - |
| Sales/Maturities of investments | - | 40 Million | -2.62 Million | - | - | - |
| Other Investing Activities | 8.05 Million | 6.96 Million | 2.62 Million | 43.92 Million | -782 Thousand | -3.34 Million |
| Financing Cash Flow | -6.66 Million | -125.91 Million | 141.12 Million | -52.69 Million | -65.86 Million | 158.88 Million |
| Debt repayment | -100.48 Million | -10.57 Million | -24.77 Million | -98.91 Million | -108 Million | -25.17 Million |
| Dividends payments | - | -36.37 Million | -32.95 Million | -34.95 Million | -58.13 Million | -44.33 Million |
| Common Stock Repurchased | - | -441 Thousand | - | -14.66 Million | -11.11 Million | - |
| Common Stock Issuance | - | -441 Thousand | 321.67 Million | 14.66 Million | 11.11 Million | - |
| Other Financing Activities | 93.82 Million | -78.08 Million | -122.81 Million | 81.17 Million | 100.26 Million | 228.38 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 114.56 Million | -51.34 Million | -108.1 Million | 13.48 Million | 36.45 Million | -60.57 Million |
| Other working capital | -97.74 Million | 205.13 Million | 22.22 Million | 16.54 Million | 5.33 Million | 20.98 Million |
| Cash at beginning of period | 277.98 Million | 303.44 Million | 224.88 Million | 160.99 Million | 156.86 Million | 116.96 Million |
| Cash at end of period | 219.39 Million | 277.98 Million | 303.44 Million | 224.88 Million | 160.99 Million | 156.86 Million |
| Capital Expenditure | -221.35 Million | -167.85 Million | -80.33 Million | -103.19 Million | -141.9 Million | -99.05 Million |
| Effect of forex changes on cash | -4000.00 | 3.19 Million | -6.1 Million | 10 Thousand | -664 Thousand | -2.22 Million |
| Net cash flow / Change in cash | -58.59 Million | -25.45 Million | 78.55 Million | 63.88 Million | 4.13 Million | 39.89 Million |
| Free Cash Flow | -26.55 Million | 50.3 Million | -19.58 Million | 201.77 Million | 68.86 Million | 54.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 26.48 Million | 4.77 Million | -39.9 Million | -17.83 Million | -3.35 Million | 28.4 Million |
| Depreciation & Amortization | 46.57 Million | 47.27 Million | 50.53 Million | 195.8 Million | 49.24 Million | 47.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 21.8 Million | -164.58 Million | 106.48 Million | 16.82 Million | 105.51 Million | -120.86 Million |
| Other non-cash items | 97.29 Million | 67.8 Million | 21.13 Million | 15 Thousand | -49.1 Million | 26.02 Million |
| Investing Cash Flow | -38.67 Million | -48.33 Million | -108.22 Million | -246.73 Million | -43.96 Million | -31.5 Million |
| Investments in PPE | -32.97 Million | -49.67 Million | -81.61 Million | -221.35 Million | -44 Million | -31.95 Million |
| Acquisitions | -4.37 Million | 15 Thousand | -34.66 Million | -33.43 Million | -328 Thousand | 448 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5.69 Million | 1.32 Million | 8.05 Million | 8.05 Million | 367 Thousand | - |
| Financing Cash Flow | 7.26 Million | 70.89 Million | -36.55 Million | -6.66 Million | -45.37 Million | 83.57 Million |
| Debt repayment | -22.5 Million | -76.86 Million | -53.76 Million | -100.48 Million | -75.73 Million | -35.97 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -9.48 Million | -1000.00 | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -27.16 Million | - | 17.2 Million | 93.82 Million | 30.36 Million | 119.54 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -26.96 Million | -121.27 Million | - | 114.56 Million | - | -91.95 Million |
| Other working capital | 21.8 Million | -164.58 Million | 106.48 Million | -97.74 Million | 105.51 Million | -28.91 Million |
| Cash at beginning of period | 102.68 Million | 219.39 Million | 225.91 Million | 277.98 Million | 212.95 Million | 179.37 Million |
| Cash at end of period | 170.28 Million | 102.68 Million | 219.39 Million | 219.39 Million | 225.91 Million | 212.95 Million |
| Capital Expenditure | -32.97 Million | -49.67 Million | -81.61 Million | -221.35 Million | -44 Million | -31.95 Million |
| Effect of forex changes on cash | - | - | 1000.00 | -4000.00 | -1000.00 | 1000.00 |
| Net cash flow / Change in cash | 67.6 Million | -116.71 Million | -6.52 Million | -58.59 Million | 12.95 Million | 33.58 Million |
| Free Cash Flow | 66.03 Million | -188.95 Million | 56.63 Million | -26.55 Million | 58.29 Million | -50.43 Million |
PNPNF
PDYNW
SUMICHEM
NEOGEN
BNGRF
002630